Nano-X Imaging (NNOX) Return on Capital Employed (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Return on Capital Employed of 56.28% for Q1 2026, down 2599.0% year-on-year from 2.25% in Q1 2025, and down 9.51% on a QoQ basis from 51.39% in Q4 2025.
Nano-X Imaging (NNOX) Return on Capital Employed (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Return on Capital Employed for 6 consecutive years, with 56.28% the latest figure, recorded in Q1 2026.
- Quarterly Return on Capital Employed fell 2599.0% year-over-year to 56.28% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56.28% (down 2599.0% YoY) and the FY2025 annual result came in at 46.24%, down 1792.0% from the prior year.
- Return on Capital Employed eased to 56.28% in Q1 2026 per NNOX's latest filing, from 51.39% in the prior quarter.
- Over the last five years, Return on Capital Employed for NNOX reached as high as 0.2% in Q3 2022 and fell as low as 115.35% in Q4 2022.
- A 5-year average of 36.68% and a median of 32.2% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 8947 bps — and 2023, when it soared 8547 bps.
- Year by year, Return on Capital Employed stood at 115.35% in 2022, then soared by 74 bps to 29.88% in 2023, then decreased by 4 bps to 31.01% in 2024, then slumped by 66 bps to 51.39% in 2025, then retreated by 10 bps to 56.28% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 56.28%, 51.39%, and 34.45% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -56.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.28% |
| Dec 31, 2025 | -51.39% |
| Sep 30, 2025 | -34.45% |
| Jun 30, 2025 | -32.64% |
| Mar 31, 2025 | -30.29% |
| Dec 31, 2024 | -31.01% |
| Sep 30, 2024 | -29.67% |
| Jun 30, 2024 | -32.20% |
| Mar 31, 2024 | -32.03% |
| Dec 31, 2023 | -29.88% |
| Sep 30, 2023 | -50.78% |
| Jun 30, 2023 | -49.64% |
| Mar 31, 2023 | -48.52% |
| Dec 31, 2022 | -115.35% |
| Sep 30, 2022 | 0.20% |
| Jun 30, 2022 | 0.20% |
| Mar 31, 2022 | 0.14% |
| Dec 31, 2021 | -25.88% |
| Sep 30, 2021 | -27.37% |
| Jun 30, 2021 | -24.62% |